Afeng Yang
Impact in
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 8
- Graphene and Nanomaterials Applications 1
-
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 3
- T-cell and B-cell Immunology 1
- Co-authors
- Feng Lv (10 shared papers)Xia Dong (10 shared papers)Deling Kong (5 shared papers)Jie Liang (3 shared papers)Zhiyong Qian (2 shared papers)Yun Bai (4 shared papers)Dunwan Zhu (5 shared papers)Deling Kong (2 shared papers)
- Journals
- Biomaterials (2 papers)ACS Applied Materials & Interfaces (2 papers)Acta Biomaterialia (2 papers)Sensors and Actuators B Chemical (1 paper)Soft Matter (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Afeng Yang
10 papers receiving 444 citations
Peers
Comparison fields: 5 of 57
- Immunology 185
- Biomaterials 118
- Molecular Medicine 42
- Biomedical Engineering 295
- Pharmaceutical Science 21
Countries citing papers authored by Afeng Yang
This map shows the geographic impact of Afeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afeng Yang more than expected).
Fields of papers citing papers by Afeng Yang
This network shows the impact of papers produced by Afeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afeng Yang. The network helps show where Afeng Yang may publish in the future.
Co-authors
The 20 scholars most cited alongside Afeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 117 | |
| 2 | 2019 | 88 | |
| 3 | 2019 | 60 | |
| 4 | 2018 | 48 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 31 | |
| 7 | 2018 | 26 | |
| 8 | 2018 | 19 | |
| 9 | 2022 | 12 | |
| 10 | 2018 | 8 |
About Afeng Yang
Afeng Yang is a scholar working on Biomedical Engineering, Immunology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 10 papers that have together received 447 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (3 papers), Photodynamic Therapy Research Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Contact Dermatitis and Allergies (1 paper), Graphene and Nanomaterials Applications (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Immunology (185 citations), Biomaterials (118 citations), Molecular Medicine (42 citations), Biomedical Engineering (295 citations) and Pharmaceutical Science (21 citations). Afeng Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Feng Lv, Xia Dong, Deling Kong, Jie Liang, Zhiyong Qian, Yun Bai, Dunwan Zhu, Deling Kong, Jie Liang and Tianjun Liu. Their work appears in journals such as Biomaterials, ACS Applied Materials & Interfaces, Acta Biomaterialia, Sensors and Actuators B Chemical and Soft Matter.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.